New scans may spot heart trouble early in young cancer survivors

NCT ID NCT07382141

Recruiting now Knowledge-focused Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether newer imaging techniques like special ultrasound and MRI can detect heart damage earlier in children, adolescents, and young adults who have had cancer treatment. Researchers will follow 400 participants to see how many develop heart problems. The goal is to improve monitoring and catch issues sooner.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOTOXICITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cardiotoxicity neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOTOXICITY

Contacts and locations

Locations

IRCCS - AOU di Bologna -Policlinico di Sant'Orsola UOC Pediatria
RECRUITING

Bologna, Bologna, 40138, Italy
IRCCS AOU di Bologna -Policlinico di Sant'Orsola UO Cardiochirurgia pediatrica e dell'età evolutiva
RECRUITING

Bologna, Bologna, 40138, Italy
IRCCS AOU di Bologna -Policlinico di Sant'Orsola UO Oncoematologia Pediatrica
RECRUITING

Bologna, Bologna, 40138, Italy
IRCCS AOU di Bologna Policlinico di Sant'Orsola UO Cardiologia Pediatria e dell'età evolutiva
RECRUITING

Bologna, Bologna, 40138, Italy
IRCCS AOU di Bologna Policlinico di Sant'Orsola UO Radiologia, sezione Cardio-Toraco-Vascolare
RECRUITING

Bologna, Bologna, 40138, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.